Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | FPR2 | P25090 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALPG | P10696 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25403046 | 0.94 | LMNA (0.40) | CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9 | |
| SCHEMBL2970104 | 0.86 | FPR2 (0.51) | CYP1A2CYP2C9CYP2C19NPSR1LMNA | |
| SCHEMBL25404385 | 0.82 | NPSR1 (0.47) | CYP3A4NPSR1LMNAFPR2L3MBTL1 | |
| SCHEMBL2962693 | 0.79 | CYP26A1 (0.42) | NPSR1FPR2ALDH1A1POLBNPC1 | |
| SCHEMBL25403319 | 0.77 | MAPT (0.46) | CYP3A4NPSR1LMNAL3MBTL1ALDH1A1 | |
| SCHEMBL25400901 | 0.74 | ALDH1A1 (0.38) | CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9 | |
| SCHEMBL10688674 | 0.73 | ALDH1A1 (0.44) | FPR2ALDH1A1SMN1; SMN2 | |
| SCHEMBL9806401 | 0.72 | FPR2 (0.56) | CYP1A2CYP2C9CYP2C19NPSR1LMNA | |
| SCHEMBL25400633 | 0.72 | LMNA (0.40) | CYP1A2CYP19A1CYP2C19NPSR1LMNA | |
| SCHEMBL28789383 | 0.71 | TBXA2R (0.44) | CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025079509-A1 | COMPOUND, COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | 株式会社ADEKA | 2025-04-17 | — | — | WO | disclosed |
| US-20240409681-A1 | CLATHRATE COMPOUND, EPOXY RESIN CURING AGENT, AND CURABLE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2024-12-12 | — | — | US | disclosed |
| US-20240317967-A1 | CURABLE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2024-09-26 | — | — | US | disclosed |
| EP-4424673-A1 | CLATHRATE COMPOUND, EPOXY RESIN CURING AGENT, AND CURABLE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2024-09-04 | — | — | EP | disclosed |
| CN-118369320-A | Compound, curable resin composition, and cured product | 株式会社艾迪科 | 2024-07-19 | — | — | CN | disclosed |
| CN-118076588-A | Inclusion compound, epoxy resin curing agent, and curable resin composition | 株式会社艾迪科 | 2024-05-24 | — | — | CN | disclosed |
| US-20240109869-A1 | CHARGE TRANSFER COMPLEX | ADEKA CORPORATION (JP) | 2024-04-04 | — | — | US | disclosed |
| US-20240084065-A1 | NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND | ADEKA CORPORATION (JP) | 2024-03-14 | — | — | US | disclosed |
| EP-4289883-A1 | CURABLE RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2023-12-13 | — | — | EP | disclosed |
| EP-4289837-A1 | NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND | ADEKA CORPORATION (JP) | 2023-12-13 | — | — | EP | disclosed |
| EP-4289821-A1 | CHARGE TRANSFER COMPLEX | Adeka Corporation (JP) | 2023-12-13 | — | — | EP | disclosed |
| CN-116848105-A | Novel compound and curable resin composition containing same | 株式会社艾迪科 | 2023-10-03 | — | — | CN | disclosed |
| WO-2023176703-A1 | COMPOUND, CURABLE RESIN COMPOSITION AND CURED PRODUCT | 株式会社ADEKA | 2023-09-21 | — | — | WO | disclosed |
| CN-116783230-A | Curable resin composition | 株式会社艾迪科 | 2023-09-19 | — | — | CN | disclosed |
| CN-116710436-A | Charge transfer complexes | 株式会社艾迪科 | 2023-09-05 | — | — | CN | disclosed |
| WO-2023074450-A1 | CLATHRATE COMPOUND, EPOXY RESIN CURING AGENT, AND CURABLE RESIN COMPOSITION | 株式会社ADEKA | 2023-05-04 | — | — | WO | disclosed |
| WO-2022168670-A1 | CHARGE TRANSFER COMPLEX | 株式会社ADEKA | 2022-08-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109869-A1 | CHARGE TRANSFER COMPLEX | TRMT1, ELP1, SEM1 | CYP1A2 3955/4885CYP3A4 2749/4885CYP2D6 3392/4885 |
| US-20240084065-A1 | NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND | PSMC6, CAND1, RBX1 | CYP1A2 2363/4885CYP3A4 2489/4885CYP2D6 2711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.